Plasma Xanthine Oxydoreductase (XOR) Activity in Patients Who Require Cardiovascular Intensive Care

被引：0
|
作者：
Shibata, Yusaku
Shirakabe, Akihiro
Okazaki, Hirotake
Matsushita, Masato
Goda, Hiroki
Shigihara, Syouta
Asano, Kazuhiro
Murase, Takayo
Nakamura, Takashi
Kobayashi, Nobuaki
Hata, Noritake
Asai, Kuniya
Shimizu, Wataru
机构：
来源：
CIRCULATION | 2019年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14271
引用
收藏
页数：2
相关论文
共 50 条
  • [21] TOPIROXOSTAT SHOWED THE POTENT INHIBITION OF PLASMA XANTHINE OXIDOREDUCTASE (XOR) ACTIVITY COMPARED WITH OTHER XOR INHIBITOR ON TYPE 2 DIABETIC MICE
    Nakamura, Takashi
    Nampei, Mai
    Murase, Takayo
    Ashizawa, Naoki
    Iwanaga, Takashi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [22] Letter by Kataoka, et al. Regarding Article, "Evaluation of Plasma Xanthine Oxidoreductase (XOR) Activity in Patients with Cardiopulmonary Arrest"
    Kataoka, Naoya
    Imamura, Teruhiko
    INTERNATIONAL HEART JOURNAL, 2024, 65 (01) : 70 - 70
  • [23] Myasthenic crisis patients who require intensive care unit management (vol 46, pg 440, 2012)
    Sakaguchi, Hideya
    MUSCLE & NERVE, 2013, 47 (05) : 781 - 781
  • [24] Who should care for intensive care unit patients?
    Gutsche, Jacob T.
    Kohl, Benjamin A.
    CRITICAL CARE MEDICINE, 2007, 35 (02) : S18 - S23
  • [25] Reply to Letter by Kataoka, et al. Regarding Article, "Evaluation of Plasma Xanthine Oxidoreductase (XOR) Activity in Patients with Cardiopulmonary Arrest"
    Shibata, Yusaku
    Shirakabe, Akihiro
    Matsushita, Masato
    Nakamura, Takashi
    Asai, Kuniya
    INTERNATIONAL HEART JOURNAL, 2024, 65 (01) : 166 - 167
  • [26] Outcome of Paediatric Patients with Hematopoietic Stem Cell Transplantation who Require Intensive Care Support: A Single Institution Experience
    Akcay, A.
    Agageldi, A.
    Atay, D.
    Erbey, F.
    Seferkolli, F.
    Sipahi, S.
    Citak, A.
    Ozturk, G.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S268 - S269
  • [27] INTENSIVE CARE EXPERIENCES OF CARDIOVASCULAR SURGERY PATIENTS
    Tosun, B.
    Aslan, O.
    INTENSIVE CARE MEDICINE, 2013, 39 : S404 - S405
  • [28] CARDIOVASCULAR REGULATION IN UNSELECTED INTENSIVE CARE PATIENTS
    Malberg, H.
    Siebig, S.
    Suhrbier, A.
    Bretthauer, G.
    Schoelmerich, J.
    Wrede, C. E.
    INTENSIVE CARE MEDICINE, 2009, 35 : 282 - 282
  • [29] The Tanta University risk model could help identify patients with acute poisoning who would require intensive care unit level of care
    Flack, Maria
    Koop, Felix
    Zellner, Tobias
    Heier, Eva-Carina
    Geith, Stefanie
    Eyer, Florian
    Rabe, Christian
    Schmoll, Sabrina
    CLINICAL TOXICOLOGY, 2024, 62 (06) : 352 - 356
  • [30] Elevated plasma xanthine oxidoreductase activity predicts cardiovascular events in patients with heart failure with preserved ejection fraction
    Watanabe, K.
    Watanabe, T.
    Otaki, Y.
    Shishido, T.
    Kato, S.
    Tamura, H.
    Nishiyama, S.
    Takahashi, H.
    Arimoto, T.
    Watanabe, M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 47 - 47
12345